Stockreport

Analysts Are Upgrading Silence Therapeutics plc (NASDAQ:SLN) After Its Latest Results [Yahoo! Finance]

Silence Therapeutics Plc - American Depository Share  (SLN) 
PDF Unfortunately, Silence Therapeutics delivered a serious earnings miss. Revenues of UK£25m were 13% below expectations, and statutory losses ballooned 74% to UK£1.17 per [Read more]